Ultragenyx Pharmaceutical Inc. (RARE)
Market Closed
17 Jul, 20:00
$
29. 28
-0.94
-3.1105%
$
3.33B Market Cap
- P/E Ratio
- Div Yield
1.5M Volume
-8.23 Eps
$ 30.22
Previous Close 
Want to track RARE and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
| Name | Time | Cons. EPS | Eps |
|---|---|---|---|
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
RARE Earnings Reports FAQ
What is the earnings per share (EPS) for RARE?
The current EPS is -8.23.
What is the company's earnings growth rate?
Ultragenyx Pharmaceutical Inc has not announced its next earnings release date. You can monitor upcoming announcements in Marketlog's earnings calendar or in the company profile.
When is the next earnings release date?
Ultragenyx Pharmaceutical Inc has not announced its next earnings release date.
What were the most recent quarterly earnings?
The most recent quarterly earnings for Ultragenyx Pharmaceutical Inc are not available at this time.
What is the price-to-earnings (P/E) ratio?
There is no P/E ratio for RARE at this time, as Ultragenyx Pharmaceutical Inc has no recent EPS data to calculate it.
